Trezix
NDC Package 66992-840-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Trezix is see also Warning section. Marketed by Wraser Llc, this product is identified by NDC 66992-840 and is authorized under FDA application ANDA204785.

Identification & Billing

NDC Package Code
66992-840-10
Package Description
100 CAPSULE in 1 BOTTLE
Product Code
11-Digit Billing Format
66992084010
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 1190201 - TREZIX 16 MG / 320.5 MG / 30 MG Oral Capsule
  • RxCUI: 1190201 - acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix]
  • RxCUI: 1190201 - APAP 320.5 MG / Caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule [Trezix]
  • RxCUI: 1190201 - Trezix (acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG) Oral Capsule
  • RxCUI: 1596108 - acetaminophen 320.5 MG / caffeine 30 MG / dihydrocodeine bitartrate 16 MG Oral Capsule

Clinical Specifications

Proprietary Name
Trezix
Dosage Form
-
Usage Information
See also Warning section. This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (dihydrocodeine), a non-opioid pain reliever (acetaminophen), and caffeine. Dihydrocodeine works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. Caffeine increases pain relief, especially for certain types of headaches.

Regulatory & Marketing

Labeler Name
Wraser Llc
FDA Application #
ANDA204785
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-01-2014
Listing Expiration
12-31-2023
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66992-840-10 identifies a specific commercial package of 100 capsule in 1 bottle of Trezix, labeled by Wraser Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Wraser Llc on December 01, 2014. The current certification is valid through December 31, 2023.

What are the primary indications for this medication?

See also Warning section. This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (dihydrocodeine), a non-opioid pain reliever (acetaminophen), and caffeine. Dihydrocodeine works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever. Caffeine increases pain relief, especially for certain types of headaches.

How is this Wraser Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66992084010. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66992-840-10
11-Digit CMS (5-4-2)
66992-0840-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.